William Grossman

Director & Interim Chief Medical Officer

Director & Interim Chief Medical Officer at enGene Therapeutics Inc., filing insider transactions on 2026-09-22.

Total Purchases

$10K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1

1 total filings

Active Since

2026-09-22

Last: 2026-09-22

Companies

enGene Therapeutics Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-22	ENGN	Purchase	5,102	$1.97	$10K	5,102	SEC ↗

William Grossman (enGene Therapeutics Inc.) Insider Trades | Tormere